Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 33913444!ä!33913444 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Esp+Salud+Publica 2021 ; 95 (ä): ä Nephropedia Template TP {{tp|p=33913444|t=2021. Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario |pdf=|usr=}}{{33913444}} gab.com Text Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario JO: Rev Esp Salud Publica http://www.kidney.de/pget.php?&tw=1&pmid=33913444 #FOAvip OBJECTIVE: A first protective dose of vaccine may allow delaying the second dose in a context of low supply. The objective is to assess the effectiveness of a single dose of vaccine against SARS-CoV-2 (BNT162b2) after twelve days of its administration in healthcare personnel (HCP) of a Health Department. METHODS: A case-control study was made. HCP with suspected COVID-19 and HCP close contacts of COVID-19 cases were included between January 27 and February 7, 2021. They were PCR tested for SARS-CoV-2; those with positive PCR were considered cases and those with negative PCR were considered controls. The crude (VE) and adjusted (VEa) vaccine effectiveness to prevent COVID-19 cases and their 95% confidence interval were calculated using the formula VE = (1-Odds ratio) x 100. RESULTS: 268 HCP were included, of which 70 (26.1%) were considered cases and 198 (73.9%) controls. The frequency of vaccine exposure in cases was 55.7% vs. 69.7% in controls (p=0.035). The VEa of the first vaccine dose was 52.6% (95%CI: 1.1-77.3). The VEa in the subgroup of HCP studied for suspected disease was 74.6% (CI95%: 38.4-89.5). CONCLUSIONS: One dose of BNT162b2 vaccine against SARS-CoV-2 offers early protection after twelve days of administration. These data could be considered to adapt strategies and consider postponing the second dose in situations of limited vaccine supply in order to achieve the maximum number of people covered with a first dose. Twit Text FOAVip Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario ????Rev Esp Salud Publica http://www.kidney.de/pget.php?&tw=1&pmid=33913444 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33913444 #FOAvip English Wikipedia <ref>{{Cite pmid|33913444}}</ref> Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario #MMPMID33913444 Gras-Valenti P; Chico-Sanchez P; Algado-Selles N; Jimenez-Sepulveda NJ; Gomez-Sotero IL; Fuster-Perez M; Cartagena-Llopis L; Sanchez-Valero M; Cerezo-Milan P; Martinez-Tornero I; Tremino-Sanchez L; Nadal-Morante V; Monerris-Palmer M; Esclapez-Martinez A; MorenodeArcos-Fuentes E; Escalada-Martin I; Escribano-Canadas I; Merino-Lucas E; Rodriguez-Diaz JC; Sanchez-Paya J Rev Esp Salud Publica 2021[Apr]; 95 (ä): ä PMID33913444show ga OBJECTIVE: A first protective dose of vaccine may allow delaying the second dose in a context of low supply. The objective is to assess the effectiveness of a single dose of vaccine against SARS-CoV-2 (BNT162b2) after twelve days of its administration in healthcare personnel (HCP) of a Health Department. METHODS: A case-control study was made. HCP with suspected COVID-19 and HCP close contacts of COVID-19 cases were included between January 27 and February 7, 2021. They were PCR tested for SARS-CoV-2; those with positive PCR were considered cases and those with negative PCR were considered controls. The crude (VE) and adjusted (VEa) vaccine effectiveness to prevent COVID-19 cases and their 95% confidence interval were calculated using the formula VE = (1-Odds ratio) x 100. RESULTS: 268 HCP were included, of which 70 (26.1%) were considered cases and 198 (73.9%) controls. The frequency of vaccine exposure in cases was 55.7% vs. 69.7% in controls (p=0.035). The VEa of the first vaccine dose was 52.6% (95%CI: 1.1-77.3). The VEa in the subgroup of HCP studied for suspected disease was 74.6% (CI95%: 38.4-89.5). CONCLUSIONS: One dose of BNT162b2 vaccine against SARS-CoV-2 offers early protection after twelve days of administration. These data could be considered to adapt strategies and consider postponing the second dose in situations of limited vaccine supply in order to achieve the maximum number of people covered with a first dose. |*COVID-19 Vaccines[MESH] |*Health Personnel[MESH] |Adult[MESH] |BNT162 Vaccine[MESH] |COVID-19 Nucleic Acid Testing[MESH] |COVID-19/diagnosis/*prevention & control[MESH] |Case-Control Studies[MESH] |Female[MESH] |Humans[MESH] |Logistic Models[MESH] |Male[MESH] |Middle Aged[MESH] |Spain[MESH]Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la CO(epmc).pdf DeepDyve Pubget Overpricing